Výsledky vyhledávání - "Javier Cambronero"

Akademický článek

Conocimientos del profesional sobre la sexualidad del ostomizado

Autor: Yovana Rodríguez-Maldonado, Teresa Sánchez-Moreno de Juan, Alicia Ruiz de la Hermosa, Inés Naranjo-Peña, Virginia de Gea-López, Javier Cambronero-Santos

Publikováno v: Cirugía y Cirujanos, Vol 91, Iss 4 (2023)

Antecedentes: Una ostomía influye significativamente en la vida de la persona, alterando su esfera biopsicosocial y sexual, y afectando a sus relaciones interpersonales. Material y método: Estudio observacional, descriptivo y transversal. Mediante

Externí odkaz: https://doaj.org/article/563d786010f6449fbe1ad324f1cbe003

Zobrazit plný text záznamu

Akademický článek

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

Autor: Jose E. Batista, Heinz Kölbl, Sender Herschorn, Tomasz Rechberger, Javier Cambronero, Michael Halaska, Alex Coppell, Mathilde Kaper, Moses Huang, Emad Siddiqui

Publikováno v: Therapeutic Advances in Urology, Vol 7 (2015)

Objective: To compare the efficacy and safety of mirabegron 50 mg and solifenacin 5 mg in overactive bladder (OAB) patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy. Patients and methods: This randomized, double-bli

Externí odkaz: https://doaj.org/article/408c607d50924e1ca9f74329f99aebe2

Zobrazit plný text záznamu

Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study

Autor: Steven A. Kaplan, Javier Cambronero Santos, Steve Foley, John Hairston, Kevin T. McVary, Rita M. Kristy, Sender Herschorn, Nurul Choudhury

Publikováno v: Urology. 147:235-242

OBJECTIVE To analyze the safety of mirabegron add-on therapy in men with overactive bladder symptoms concurrently receiving tamsulosin for lower urinary tract symptoms associated with benign prostatic hyperplasia. METHODS The Phase 4 PLUS study compr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645975d2620deb3ea0d60988ac3cf29a
https://doi.org/10.1016/j.urology.2020.09.040

Zobrazit plný text záznamu

[Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)]

Autor: Javier, Cambronero, Jose Manuel, Osca-García, Sergio, Merino-Salas, Juan Manuel, Miguel, Cristina, Borralleras, Emilio, López-Alcina

Publikováno v: Archivos espanoles de urologia. 75(3)

To assess the effectivenessand tolerability of treatment with P africanum(P. africanum) in patients with lower urinary tractsymptoms (LUTS) associated with benign prostatichyperplasia (BPH) in routine clinical practice.Cross-sectional observationalst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1d377f814065187c865725dae84efa9e
https://pubmed.ncbi.nlm.nih.gov/35435166

Zobrazit plný text záznamu

[IPSS storage score as a predictive tool of quality of life improvement to apply in therapeutic interventions.]

Autor: Javier, Cambronero-Santos, Borja Manuel, Fernández-Félix, Ana María, Mora-Blázquez

Publikováno v: Archivos espanoles de urologia. 73(2)

The questionnaire International Prostate Symptom Score (IPSS) is well known and used in clinical practice as diagnostic tool and allows for obtaining a total score regarding the severity of the urinary symptoms. The objective of this analysis is to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9d319a5a38dd0db4ccd8124f933cf194
https://pubmed.ncbi.nlm.nih.gov/32124837

Zobrazit plný text záznamu

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

Autor: David R. Staskin, Kevin T. McVary, Sender Herschorn, Christopher R. Chapple, John Hairston, Steven A. Kaplan, Steve Foley, Nurul Choudhury, Carol R. Schermer, Javier Cambronero Santos, Rita M Kristy

Publikováno v: Journal of Urology
Journal of Urology, Elsevier, 2020, 203 (6), pp.1171-1171. ⟨10.1097/ju.0000000000000738.01⟩

PLUS investigated the efficacy and safety of mirabegron add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying lower urinary tract symptoms attributable to benign prostatic hyperplasia.In this phase 4 study a 4-wee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9120fbe0f5a8161fe87a79b60473390
https://hal.archives-ouvertes.fr/hal-03228620

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání